Prime Medicine, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.137; its P/E ratio is -2.47; Prime Medicine, Inc. is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 168.00K	-	-	-	$ 0.00
Gross Profit	$ 168.00K	-	-	-	-
EBIT	$ -114.21M	$ -9.85M	$ -39.60M	-	$ -31.66M
EBITDA	$ -110.70M	$ -6.39M	$ -36.33M	-	$ -31.02M
Net Income Common Stockholders	$ -26.25M	$ -50.71M	$ -78.79M	-	$ -35.71M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 41.57M	$ 43.96M	$ 249.52M	$ 293.92M	$ 146.66M
Total Assets	$ 193.85M	$ 239.15M	$ 316.95M	$ 360.31M	$ 215.26M
Total Debt	$ 13.63M	$ 17.04M	$ 25.96M	$ 28.75M	$ 31.44M
Net Debt	$ -27.94M	$ -26.92M	$ -223.55M	$ -265.18M	$ -115.23M
Total Liabilities	$ 60.78M	$ 45.19M	$ 38.15M	$ 44.04M	$ 42.56M
Stockholders Equity	$ 133.07M	$ 193.96M	$ 278.80M	$ 316.27M	$ 172.70M
Cash Flow	-
Free Cash Flow	$ -45.70M	$ -42.08M	$ -43.56M	$ -35.53M	$ -34.89M
Operating Cash Flow	$ -43.86M	$ -39.17M	$ -41.56M	$ -30.71M	$ -30.10M
Investing Cash Flow	$ 41.28M	$ -37.77M	$ -12.66M	$ -13.69M	$ -13.51M
Financing Cash Flow	$ 194.00K	$ 318.00K	$ 68.00K	$ 184.07M	$ -683.00K

Currency in USD

Prime Medicine, Inc. Earnings and Revenue History

Income Statement >

Prime Medicine, Inc. Debt to Assets

Balance Sheet >

Prime Medicine, Inc. Cash Flow

Cash Flow >

Prime Medicine, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing